The Influence of COX-2 Single Nucleotide Polymorphisms on Abdominal Aortic Aneurysm Development and the Associated Inflammation

Angiology

Volumn 60, Issue 5, 2009, Pages 576-581

  Badger, Stephen A ^a   Soong, Chee V ^a   Young, Ian S ^b   McGinty, Ann ^b   Mercer, Caroline ^b   Hughes, Anneq E ^b  

^a BELFAST CITY HOSPITAL   (United Kingdom)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Abdominal aortic aneurysm; C reactive protein; COX 2; Genetic polymorphism

Indexed keywords

C REACTIVE PROTEIN; CYCLOOXYGENASE 2;

ABDOMINAL AORTA ANEURYSM; AGED; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ANALYSIS; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; PROTEIN BLOOD LEVEL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 70350503403     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/0003319709335027     Document Type: Article

References (32)

1. Reed D., Reed C., Stemmermann G., Hayashi T. Are aortic aneurysms caused by atherosclerosis ? Circulation. 1992 ; 85 (1). 205-211.
2. Tilson MD Aortic aneurysms and atherosclerosis. Circulation. 1992 ; 85 (1). 378-379.
3. Xu C., Zarins CK, Glagov S. Aneurysmal and occlusive atherosclerosis of the human abdominal aorta. J Vasc Surg. 2001 ; 33 (1). 91-96. (Pubitemid 32109611)
4. Fitzpatrick FA Cyclooxygenase enzymes: regulation and function. Curr Pharm Des. 2004 ; 10 (6). 577-588.
5. Smith WL, Langenbach R. Why there are two cyclooxygenase isozymes? J Clin Invest. 2001 ; 107 (12). 1491-1495.
6. Samuelsson B., Goldyne M., Granstrom E., Hamberg M., Hammarstrom S., Malmsten C. Prostaglandins and thromboxanes. Annu Rev Biochem. 1978 ; 47: 997-1029.
7. Dempke W., Rie C., Grothey A., Schmoll HJ Cyclooxygenase-2: a novel target for cancer chemotherapy ? J Cancer Res Clin Oncol. 2001 ; 127 (7). 411-417.
8. Hla T., Neilson K. Human cyclooxygenase-2 cDNA. Proc Natl Acad Sci U S A. 1992 ; 89 (16). 7384-7388.
9. Vane JR, Bakhle YS, Botting RM Cyclooxygenases 1 and 2. Annu Rev Pharmacol Toxicol. 1998 ; 38: 97-120.
10. OĝNeill GP, Ford-Hutchinson AW Expression of mRNA for cyclooxygenase-1 and cyclooxygenase-2 in human tissues. FEBS Lett. 1993 ; 330 (2). 156-160.
11. Appleby SB, Ristimaki A., Neilson K., Narko K., Hla T. Structure of the human cyclooxygenase-2 gene. Biochem J. 1994 ; 302 (pt 3). 723-727.
12. Chen G., Wood EG, Wang SH, Warner TD Expression of cyclooxygenase-2 in rat vascular smooth muscle cells is unrelated to nuclear factor-kappaB activation. Life Sci. 1999 ; 64 (14). 1231-1242.
13. Cipollone F., Prontera C., Pini B., et al. Overexpression of functionally coupled cyclooxygenase-2 and prostaglandin E synthase in symptomatic atherosclerotic plaques as a basis of prostaglandin E(2)-dependent plaque instability. Circulation. 2001 ; 104 (8). 921-927.
14. Cipollone F., Rocca B., Patrono C. Cyclooxygenase expression and inhibition in atherothrombosis. Arterioscler Thromb Vasc Biol. 2004 ; 24 (2). 246-255.
15. Seibert K., Zhang Y., Leahy K., et al. Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain. Proc Natl Acad Sci U S A. 1994 ; 91 (25). 12013-12017.
16. Parente L., Perretti M. Advances in the pathophysiology of constitutive and inducible cyclooxygenases: two enzymes in the spotlight. Biochem Pharmacol. 2003 ; 65 (2). 153-159.
17. Kosaka T., Miyata A., Ihara H., et al. Characterization of the human gene (PTGS2) encoding prostaglandin-endoperoxide synthase 2. Eur J Biochem. 1994 ; 221 (3). 889-897. (Pubitemid 24146188)
18. Cipollone F., Toniato E., Martinotti S., et al, for the Identification of New Elements of Plaque Stability (INES) Study Group. A polymorphism in the cyclooxygenase 2 gene as an inherited protective factor against myocardial infarction and stroke. JAMA. 2004 ; 291 (18). 2221-2228.
19. Papafili A., Hill MR, Brull DJ, et al. Common promoter variant in cyclooxygenase-2 represses gene expression. Arteroscler Thromb Vasc Biol. 2002 ; 22 (10). 1631-1636.
20. Xu Q., Ji YS, Smedtje JF Jr. Sp1 increases expression of cyclooxygenase-2 in hypoxic vascular endothelium: implications for the mechanisms of aortic aneurysm and heart failure. J Biol Chem. 2000 ; 275 (32). 24583-24589.
21. Cullen L., Kelly L., Connor SO, Fitzgerald DJ Selective cyclooxygenase-2 inhibition by nimesulide in man. J Pharmacol Exp Ther. 1998 ; 287 (2). 578-582.
22. Fitzgerald GA, Patrono C. The coxibs, selective inhibitors of cyclooxygenase-2. N Engl J Med. 2001 ; 345 (6). 433-442.
23. McAdam BF, Catella-Lawson F., Mardini IA, Kapoor S., Lawson JA, FitzGerald GA Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2. Proc Natl Acad Sci U S A. 1999 ; 96 (1). 272-277.
24. Melrose J., Whitelock J., Xu Q., Ghosh P. Pathogenesis of abdominal aortic aneurysms: a possible role of differential production of proteoglycans by smooth muscle cells. J Vasc Surg. 1998 ; 28 (4). 676-686.
25. Juvonen J., Surcel HM, Satta J., et al. Elevated circulating levels of inflammatory cytokines in patients with abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol. 1997 ; 17 (11). 2843-2847.
26. Newman KM, Jean-Claude J., Li H., Ramey WG, Tilson MD Cytokines that activate proteolysis are increased in abdominal aortic aneurysms. Circulation. 1994 ; 90 (5 pt 2). 11224-11227.
27. Koch AE, Kunkel SL, Pearce WH, et al. Enhanced production of the chemotactic cytokines interleukin-8 and moncyte chemoattractant protein-1 in human abdominal aortic aneurysms. Am J Pathol. 1993 ; 142 (5). 1423-1431.
28. Herron GS, Unemori E., Wong M., Rapp JH, Hibbs MH, Stoney RJ Connective tissue proteinases and inhibitors in abdominal aortic aneurysms. Involvement of the vasa vasorum in the pathogenesis of aortic aneurysms. Arterioscler Thomb. 1991 ; 11 (6). 1667-1677.
29. Badger SA, Soong CV, OĝDonnell ME, Mercer C., Young IS, Hughes AE C-reactive protein (CRP) elevation in patients with abdominal aortic aneurysm is independent of the most important CRP genetic polymorphism. J Vasc Surg. 2009 ; 49 (1). 178-184.
30. Hegener HH, Diehl KA, Kurth T., Gaziano JM, Ridker PM, Zee RYL. Polymorphisms of prostaglandinendoperoxide synthase 2 gene, and prostaglandin-E receptor 2 gene, C-reactive protein concentrations and risk of atherosclerosis: a nested case-control approach. J Thromb Haemost. 2006 ; 4 (8). 1718-1722.
31. Kohsaka S., Volcik KA, Folsom AR, et al. Increased risk of incident stroke associated with the cyclooxygenase 2 (COX-2) G-765C polymorphism in African-Americans: the Atherosclerosis Risk in Communities Study. Atherosclerosis. 2008 ; 196 (2). 926-930.
32. Huuskonen KH, Kunnas TA, Tanner MM, et al. COX-2 gene promoter polymorphism and coronary artery disease in middle-aged men: the Helsinki sudden death study. Mediators Inflamm. 2008 ; 2008: 289453.